The Board of Directors of Metronic announced that Metronic Medicare, a wholly- owned subsidiary of the company had on 22 February 2021, been awarded a Letter of Intent ("LOI") by MTPS for the propose acquisition of the SARS-COV-2 NAb Immune System Rapid Test Kit from Metronic Medicare ("Project"). The salient terms of the LOI are set out as below: Request of 200 sample test kit to register with local relevant authorities; The indicative products price shall be as below:- Quantity (set) was 30,000,000 and Total Amount USD 210,000,000; The Parties shall as soon as practicable negotiate in good faith and enter into a definitive agreement within one month from the date of the LOI ("Period"), failing which, the Period shall be automatically extended for a period of another one month ("Extended Period"); and In the event the Agreement is not executed within the Period or the Extended Period, this LOI shall be automatically terminated and void.